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Abstract
Remarkably, although cardiac disease accounts for the largest proportion of adult mortality and morbidity in the
industrialized world, the genetic programs controlling early cardiogenesis are largely incompletely understood. To better
understand this process, we set out to identify genes whose expression is enriched within early cardiac fated populations,
obtaining the transcriptional signatures of mouse embryonic stem cells (mESCs) at defined intervals during their
differentiation along a cardiac path. We compared the RNA profiles of cardiac precursors cells (CPCs) with time-matched
non-CPCs and undifferentiated mESCs, using a transgenic mESC line harboring an Nkx2-5 cardiac-specific regulatory
sequence driving green fluorescent protein (GFP) to facilitate selection of CPCs. We identify 176 transcripts that are
significantly elevated in their abundance within CPCs compared with other assayed populations, predicting that they will
likely play a role in cardiogenesis. Of note, approximately 24% (43/176) of the cardiogenic candidate transcripts have known
roles in cardiac function or development. Importantly, we evaluated the biological relevance of a significant subset 31/133
(23%) of the remaining candidate genes by in situ hybridization at multiple time points during development (embryonic
day, E7.5–9.5) and report that all were expressed in key cardiac structures during cardiogenesis. Furthermore 9/31, of which
many were previously uncharacterized, were detected as early as the formation of the cardiac crescent. These data
demonstrate the potential power of integrating genomic approaches with mESC differentiation to illuminate
developmental processes, and provides a valuable resource that may be mined to further elucidate the genetic programs
underlying cardiogenesis.
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Introduction
The heart is the first organ to form and function in the
vertebrate embryo [1]. It is derived from the mesoderm that arises
from the primitive streak during gastrulation. In mouse, cardiac
progenitors migrate from the middle and anterior region of the
streak to a region under the head folds on either side of the midline
by E6.5 [2]. At approximately E7.5, these progenitor cells extend
across the midline forming what is termed the cardiac crescent, the
first anatomically distinct cardiac structure in the developing
embryo. The cells of the crescent migrate ventrally to form a linear
heart tube consisting of an outer myocardial layer and an inner
endocardial layer. Over the next 48 hours, this heart tube
undergoes progressing rightward looping, giving rise to a four
chambered heart by E10.5.
The developing heart was recently demonstrated to comprise
two distinct fields identified through the expression of unique
markers, and each giving rise to specific cardiac structures [3,4].
The secondary heart field, which contributes to the right ventricle
and outflow tract, is distinguished by Hand2, Isl1, and Fgf10
expression [3–5]. Another key cardiac gene, Nkx2-5, is simulta-
neously expressed in both the primary and secondary heart fields,
making it a very useful marker for cardiac fated cells during
development. Nkx2-5 is a homeodomain transcription factor and
an ortholog of the Drosophilia gene tinman, a gene that is essential
for cardiac specification in the fly [6]. In mouse, Nkx2-5 appears
dispensable for specification and formation of the cardiac crescent.
However, it is essential for stages beyond heart tube formation,
with embryos lacking Nkx2-5 exhibiting looping defects and dying
in utero (E9.5–E11.5) [7]. Although recent studies have provided
further insight to mammalian heart development, our understand-
ing of this complicated process is incomplete; elucidation of these
processes has been greatly hampered by technical difficulties in
studying early mammalian development in utero.
We, and others, have attempted to overcome this complication
by utilizing the differentiation of embryonic stem cells (ESCs) as a
model to study early developmental processes in vitro. The
expression patterns of several key cardiac genes during ESC
differentiation is known to closely reflect their endogenous
expression during cardiogenesis in vivo [8,9]. The differentiation
of ESCs toward cardiac populations that include cardiomyocytes
are characterized by a temporally and spatially ordered expression
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2176of specific genes. Brachyury expression which specifies mesoderm is
followed by Gata4 and Nkx2-5 (required for cardiac lineage
development), leading to the expression of aMhc, bMhc and Cx43
which mark distinct maturation stages [10], and ultimately
generating myofibrils and sarcomeres characteristic of mature
cardiomyocytes [9]. Although several studies have identified
multipotent cardiac progenitor cells (CPCs) in ES-derived popula-
tions [11–14], we have recently demonstrated that such CPCs are
capable of forming all cardiac lineages, including endothelial and
vascular smooth muscle in addition to cardiomyocytes [11–14].
AlthoughthesestudiesverifythecardiacpotentialofESCsmosthave
been performed using multi-lineage populations of cells in which the
cardiac lineage represents a minor population.
We set out to establish whether ESCs can serve as a model to
provide genetic information on cardiogenesis, determining and
comparing transcriptional profiles at different stages during
differentiation. To this end we have isolated GFP positive
(GFP
+) and GFP
2 populations at three developmentally significant
time points during their differentiation, simultaneously separating
GFP
+ and GFP
2 populations within embryoid bodies. Our first
time point was established as the undifferentiated starting
population and was designated day 0 (D0). At this time our
mESCs express markers of pluripotency such as Oct4 and SSEA-1
[11]. As differentiation proceeds, these mESCs decrease expres-
sion of the pluripotency markers and by the fourth day of the
differentiation process (D4) these mESCs this cell population
expresses the mesodermal marker Brachyury [11]. This was selected
as our second time point. The third and final time point utilized in
this study, day 6 (D6), is characterized by the initiation of robust
Nkx2-5 expression, a critical gene expressed in the earliest stages of
cardiac development, the formation of the cardiac crescent. This
pivotal cardiac marker is expressed within a substantial subset of
the differentiating population, but not in all cells and it remains
expressed for the life of the cardiomyocyte in vitro and in vivo.
Importantly expression of the GFP reporter occurs in concert with
Nkx2-5 expression in the cardiac fated cell population, making it
possible to obtain a discrete population of cardiac Nkx2-5
expressing by fluorescence activated cell sorting (FACS). RNA
isolated from these populations was then subjected to array-based
transcript profiling analyses. We compared the expression profile
of the GFP
+ population with earlier time points and time matched
non-cardiac fated cells (GFP
2).
We predicted that transcripts upregulated in the GFP
+
population relative to earlier time points or non-cardiac fated
cells, would most likely be genes expressed in cardiovascular
structures during cardiac development. Of the genes upregulated
in the GFP
+ population, 43/176 (24%) have known roles in
cardiac or hematopoietic development or function. The significant
remainder (133/176) consists of genes not previously known to
function in cardiogenesis. Indeed, more than 20% (52/260) of the
transcripts differentially regulated in the GFP
+ population have no
known function. We then asked what which genes lacking an
identified role in cardiac development were appropriately
expressed in cardiac structures. Through the assessment of 31
candidate genes at 3 critical points during heart development:
E7.5, the cardiac crescent; E8.5, the heart tube; and E9.5, the
looping heart; we demonstrated that all were expressed as
predicted within appropriate cardiovascular structures, including
9/31 (29%) that were expressed in the cardiac crescent or heart
tube at the earliest stages of heart formation. These data validate
the power of ESC differentiation strategies as a model for
mammalian development and, in combination with established
genomic technologies, as a powerful gene discovery tool for
developmental processes.
Methods
Cell Culture and Differentiation Strategy
mESCs were differentiated through embryoid body [15] forma-
tion (hanging droplet technique) as described [16]. Following
primary mouse embryonic fibroblasts (PMEF) feeder subtraction,
mESCs were dissociated and resuspended in differentiation medium
at a density of 56104 cells/mL. Cells at this time point were
designated as day 0 (D0). Following incubation for two days, the EBs
were transferred, in suspension, to poly-HEMA coated tissue culture
dishes to prevent cell attachment and grown in medium containing
ascorbic acid [17] which was replenished every 3 days thereafter.
The generation of themESCline usedinthese experimentshas been
previously described [11] and harbors a 6.7 kb Nkx2-5 cardiac
specific enhancer sequence [15] driving GFP.
Fluorescence Activated Cell Sorting
EBs were harvested on days 4 and 6 (D4 and D6), washed in
PBS for 30 minutes at 37uC then resuspended in 0.25% trypsin for
4, and 7 minutes, respectively. Cells from each time point (D0, D4,
and D6) were sorted using the BD Biosciences FACSAria
TM Cell
sorting system. D6 cells alone were sorted into GFP+ and GFP2
fractions; a small fraction of these cells were collected in PBS for
post-sort analysis, the remainders were sorted into RLT buffer
(RNeasy, Qiagen) as were the D0 and D4. Data collection for each
time point was performed in triplicate.
RNA Preparation and Array Hybridization
The isolated RNA was amplified and labeled using the
Affymetrix Two Cycle
TM labeling kit according to protocols
described by the manufacturer. The resulting labeled cRNA was
hybridized to Affymetrix mouse genome GeneChip 430 arrays,
version 2.0. Fluorescence was detected using the Affymetrix-
GS3000 GeneArray
TM Scanner and image analysis of each
GeneChip
TM was performed using the GeneChip
TM Operating
System software from Affymetrix.
Data Analysis
Microarray data were preprocessed (background subtraction,
normalization, and summarization) using robust multi-chip
analysis (RMA) [18]. A linear mixed-model ANOVA was used
to detect differential transcript expression based on the time point
and presence or absence of a GFP population (GFP positive
populations were cells fated along a cardiac lineage). A comparison
was made among the Day 6 GFP+ population and the Day 0, Day
4, and Day 6 GFP- population. All analyses were performed using
the PartekH Genomic Suite software package version 6.3 Beta.
Quantitative RT-PCR
RNA was reverse transcribed using random decamers and
MMLVRT. RNA levels were measured using FAM labeled
probes from Applied Biosystems: Ramp2 (Mm00490256_g1),
Nkx2-5 (Mm00657783_m1), Tek (Mm00443242_m1), Gyg1
(Mm00516516_m1), Myla (Mm00440378_m1), Gata4
(Mm00484689_m1), and Isl1 (Mm00627860_m1); all probes were
normalized to 18S (Hs99999901_s1). Samples were collected in an
Applied Biosystems ABIPrism 7900HT and analyzed using
SDS2.1 software.
Gene Ontology Annotation
The ANOVA filtered Affymetrix Mouse 430_2.0 probe sets
were assigned to functional categories based largely on Gene
Ontology Consortium (GO) annotation [19], (http://geneontology.
ESCs Identify Cardiac Genes
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by the Mouse Genome Database (MDG) of Mouse Genome
Informatics [20], http://www.informatics.jax.org/. Affymetrix ex-
pression probes were mapped to a transcript in their NetAffx
Annotation files, which also include a subset of the genes’ GO
annotations. To supplement the Affymetrix GO annotation this
analysis also employed the SpotfireH (www.spotfire.com) Functional
Genomics platform to access full GO annotation.
Nucleic Acid in situ Hybridization
Probes 1–11 of the candidate genes were generated from E15
whole mouse RNA. A ,600 bp region from PCR amplified from
the cDNA and TA cloned into the Invitrogen PCRII vector
(Primers available upon request). Probes 12–31 were obtained
through Invitrogen Clone Ranger . Nkx2-5 probe was a gift
from Dr. Richard P. Harvey [21]; Isl1 probe was a gift from Dr.
Sylvia Evans [5]. Digoxygenin-labelled riboprobes were synthe-
sized using Sp6, T3, and T7 RNA Polymerase. CD-1 embryos
were collected on days E7.75, E8.5, and E9.5, and in situ
hybridization was performed as previously described [22].
Results
Isolation of ESCs Differentiating Along a Cardiac Lineage
In an effort to give access to cardiac fated populations at the
earliest stages of development, we have made use of a transgenic
mESC line (Nkx2-5-GFP) containing an established cardiac specific
enhancer element of the Nkx2-5 transcription factor [15] driving
expression of the green fluorescent protein (Methods). This cell
line was subjected to cardiac differentiation strategies described in
the methods; we selected specific time points for analysis at which
transcriptional changes in key pluripotent/mesodermal/cardiac
genes indicate critical stages in cardiogenesis: D0 representing
undifferentiated mESCs; D4 corresponding to the differentiation
along a mesodermal lineage; and D6, with the onset of robust
Nkx2-5 expression in the cardiac progenitor population. Cells were
harvested at all selected time points and FAC sorted, with only the
day 6 samples were sorted into GFP
+ and GFP
2 fractions
(36.9%69.8% of the cells expressed GFP in the day 6 indicating a
high level of cardiac enrichment). In order to assess the efficiency
of our FAC sorting to discriminate between the GFP
+ and GFP
2
population, we performed an additional round of flow cytometry,
which demonstrated a high purity of the GFP
+ and GFP
2
populations, 95.7%63.4% and 99.5%61.5% respectively (Figure
S1). We isolated RNA from undifferentiated (D0), mixed (cardiac
fated and non-cardiac fated; D4), and FAC sorted D6 non-cardiac
fated (GFP negative; GFP
2) and cardiac fated (GFP positive;
GFP
+) cell populations (Figure 1); RNA isolations were performed
on independent cell isolates of each population in triplicate
(Methods)
Analyses of Transcriptional Profiles and Identification of
Cardiac Candidate Genes
We examined RNA from four groups (day 0; day 4; day 6
GFP
+; day 6 GFP
2; n=3 samples per group). RNA was isolated
from the cell populations, amplified, labeled and hybridized to
Affymetrix Genechip 430 version 2.0 arrays as described in
Methods. Expression data were normalized using Robust Multi-
chip Average (RMA), consisting of three steps: a background
adjustment, quantile normalization and finally summarization
[18]. In order to determine the integrity of the data generated in
our array experiment, we undertook several analytical approaches
Figure 1. Description Of Experimental Design. mESCs were differentiated within hanging droplets and RNA was isolated from the
corresponding undifferentiated and differentiating mESC populations at specific time points (day 0, day 4, day 6 GFP
+, and day 6 GFP
2; Methods).
Isolated RNA populations were then hybridized to Affymetrix 430 2.0 microarrays and the resulting transcription profiles analyzed as described in
Methods.
doi:10.1371/journal.pone.0002176.g001
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established strategies to evaluate microarray data.
Principal components analysis (PCA) is an unsupervised
technique in which the data are not segregated into groups prior
to the analysis. Instead, patterns are observed based on the output
of the analysis. To this end we used Partek software with default
settings, including a covariance dispersion matrix (Methods). The
data used to generate this plot consist of a matrix of 12 samples,
each comprising 45,101 RNA transcript intensity values. The axes
correspond to the principal components (PCs), with the first PC
axis accounting for 28.9% of the variance and the second PC axis
accounting for 19.3% of the variance. The plot showed the
samples in four groups corresponding to the four experimental
conditions. This demonstrates that the samples were distinguish-
able based on their overall gene expression profiles, that the
samples were normalized consistently, and that there were no
outlier samples (Figure 2A). Our ability to discriminate between
experimental groups by PCA was consistent with hierarchical
clustering analyses (data not shown). These analyses gave us
confidence in the integrity of our data and we therefore proceeded
to test the hypothesis that day 6 GFP
+ cells (which represented the
cardiac progenitor population) possess a unique transcriptional
signature relative to control populations (D0, D4 and D6 GFP
2).
To test this hypothesis we implemented ANOVA using a
‘‘contrast’’ of the day 6 GFP
+ versus the ‘‘control’’ populations
(Methods). We applied several false discovery rates (0.05, 0.01,
0.001), identifying 2643 (FDR=0.05), 1018 (FDR=0.01) and 297
significantly regulated probe sets, respectively (FDR=0.001;
Table 1, Table S1). We also demonstrated that a large proportion
of transcripts were significantly regulated in the day 6 GFP
+ cells
by plotting a histogram of the frequency of p-values (y-axis) versus
the observed p-value (x-axis) (Figure 2B). If our comparisons of
contrast (GFP
+) RNAs to controls (D0, D4 and D6 GFP
2) were to
demonstrate no significant differential regulation, we would expect
a random distribution of p-values resulting in 2255 p-values in each
bin. Our data demonstrated that the observed number of small p-
values is clearly overrepresented, an indication of robust power to
discriminate between the groups being compared.
To establish the integrity of the array-based data and these
statistical analyses we performed qRT-PCR on a subset of known
cardiac genes (Nkx2-5, Gata4, Isl1), as well as genes shown by
Figure 2. Determination Of Data Integrity. A. Principle components analysis (PCA) of the four experimental groups: day 0, day 4, day 6 GFP
+,
and day 6 GFP
2. B. Distribution of observed p-values. The dotted line corresponds to the frequency of p-values if they were uniformly distributed
across all bins.
doi:10.1371/journal.pone.0002176.g002
Table 1. The Numbers of Transcripts Whose Levels Vary
Significantly Between Conditions
FDR level p-value RNA Transcripts Identified
0.001 6.58610
26 297
0.01 2.26610
24 1018
0.05 2.93610
23 2643
RNA Transcripts Identified corresponds to the number of transcripts present at
each significance threshold comparison of day 6 GFP
+ cells to controls (day 0,
day 4, and day 6 GFP
2). FDR, false discovery rate; p-value, significance threshold
determined for each FDR.
doi:10.1371/journal.pone.0002176.t001
ESCs Identify Cardiac Genes
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ocytes evaluated ex vivo [23] (Tek, Gyg) (Figure 3). All qRT-PCR
data were consistent both with the published data and with the
enrichment of these transcripts in the D6 GFP
+ population relative
to the D0 and D4 populations detected within the array
experiment. These data further validated the statistical analysis
of our array data and support its potential in vivo biological
relevance. Thus we moved on to impute some biological correlates
to this large body of data.
GO Annotation of Differentially Regulated Transcripts
To determine the function of the transcripts upregulated in the
Day 6 GFP
+ population, we queried ontology databases. At FDR
#0.001, the identified 297 probe sets represented 260 unique
genes or transcripts, of which approximately 80% (208/260) had
GO annotation. The corresponding GO annotations were
established for processes, functions, or cellular locations that have
been related to cardiac differentiation and the results presented in
Table S2. The one exception is that ‘‘antigens’’, which is not a GO
classification, were selected by their MGD Nomenclature
Committee names. The resulting ontology data indicates that
there were significant fractions of genes, upregulated in the D6
GFP
+ population, responsible for cell signaling (extracellular, 24/
260, 9%; and intracellular, 26/260, 10%) as well as transcriptional
regulation (31/260, 12%). There is also a large population of
structural molecules (30/260, 12%) in this dataset, including
myosins and troponins, indicative of a cardiogenic population.
Finally the largest population of the ontology dataset is transcripts
of unknown function (52/260; 20%), and an additional 10% (27/
260) of the identified transcripts providing insufficient information
for definite classification (Figure 4). Although these data suggest
trends in biological classification of identified genes, they fall short
of determining their biological relevance.
To this end we set out to define the developmental expression of
selected candidates, we selected those transcripts that were
upregulated in GFP
+ population (n=176) choosing as a threshold
a high stringency FDR of 0.001. In addition, we selected only
those transcripts displaying a minimum fold change threshold of
+1.2. Importantly, of 176 transcripts upregulated in the cardiac
D6 population, 43 (24%) have known roles in cardiac development
or function (Table S1). Our underlying hypothesis was straight-
forward; identified genes highly likely to be expressed in key
cardiac structures during development.
Determination of Biological Significance in vivo by in situ
We selected 31 candidates of the remaining 133 for evaluation
(23%), prioritizing genes for which insufficient biological data were
available to include or exclude a role in cardiogenesis. We
determined the spatial expression of selected candidates by in situ
hybridization at mouse E7.5, E8.5, and E9.5, critical time points
for mouse embryonic heart development. To aid our analysis, we
first established the expression patterns of two known cardiac
genes; in situ hybridization was performed using probes for Nkx2-5
and Isl1 at the corresponding time points (Figure 5 A–F). The
transcript corresponding to the Nkx2-5 transcription factor is
present in the primary and secondary heart fields at E7.5, the
linear heart tube at E8.5, and throughout the looping heart at E9.5
(Figure 5 A–C). Secondly, Isl1 is expressed in the secondary
(anterior) heart field at E7.5; its expression persists in the outflow
tract at E8.5; and subsequently in the outflow tract, trigeminal
ganglia, spinal cord, and dorsal root ganglia on E9.5 (Figure 5 D–
F).
The candidates evaluated by in situ hybridization demonstrated
a wide range of expression levels and locations throughout the
studied time points. Consistent with our hypothesis that the
candidates upregulated in the GFP
+ population are expressed in
early cardiac structures, transcripts corresponding to nine of the
genes (4930544G21Rik, Ak080047, Rbm24, Ppp1r3d, Tmem108, Air,
Arhgap29, Igf2, and Igfbp5) were detected in the cardiac crescent, at
the earliest timepoint studied (E7.5) (Figure 5). Four candidates,
4930544G21Rik, Ak080047, Rbm24, and Ppp1r3d, were expressed
exclusively in the cardiac crescent (Figure 5 G, J, M, P); while
Figure 3. Confirmation of Microarray Data by qRT-PCR. A. Geometric fold change values of the selected genes (GENE names) in the contrast
of Day 6 GFP
+ versus day 0, day 4 and day 6 GFP
2. B. qRT-PCR of the selected genes at day 0, day 4 and day 6 GFP
+ time points. Error bars represent
the normalized standard deviation.
doi:10.1371/journal.pone.0002176.g003
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cardiac crescent and in other early embryonic structures (Figure 5
S, V, Y, BB, EE). At E8.5, the cell populations in which these
genes were expressed correspond to discrete cardiac structures,
with Ak080047 expressed solely in the heart tube (Figure 5K);
4930544G21Rik, Tmem108, and Rbm24 expressed in the heart
inflow tract, heart tube and outflow tract (Figure 5 H, N, T);
Ppp1r3d expressed in the inflow and outflow tracts (Figure 5Q);
Arhgap29 and Igfbp5 expressed in the branchial arches, inflow and
outflow tract (Figure 5 Z, FF); and Air and Igf2 expressed in the
inflow tract, heart tube, and outflow tract, in addition to other
embryonic tissues (Figure 5 W, CC). At E9.5, 4930544G21Rik was
expressed in the inflow tract, common atria, right ventricle,
outflow tract, and central nervous system (CNS) (Figure 5I);
whereas Ak080047 was expressed throughout the heart and CNS
(Figure 5L); similarly Rbm24 was expressed in the entire heart but
is also detectible in the somites (Figure 5O). Arhgap29 was
expressed in the inflow tract, common atria, outflow tract, and
branchial arches and other embryonic tissues (Figure 5AA); while
Ppp1r3d was inflow and outflow tracts, otic vesicle, and somites
(Figure 5R); Tmem108 was expressed in the inflow tract, heart,
outflow tract, and CNS (Figure 5U); Igfbp5 was expressed in the
inflow and outflow tracts, branchial arches, and somites (Figure
GG); finally Igf2 and Air were expressed in the inflow tract, heart,
outflow tract, and branchial arches along with other embryonic
tissues (Figure 5 X, DD).
Although transcripts corresponding to the remaining candidates
could not be detected at E7.5, many were detectable by E8.5.
AK033658 was expressed in the inflow tract of the E8.5 and E9.5
embryo, with expression also detected in the common atria and
CNS of the E9.5 embryo (Figure 6 A–B). AI465270 and Unc45b
were expressed in the inflow tract, heart, and outflow tract of the
E8.5 and E9.5 embryo (Figure 6 C–F). Other candidate transcripts
(Dlk1, 1110062M06Rik, and 8430436O14Rik) were detected in key
cardiac structures such as the branchial arches, inflow tract and
outflow tract, but not the heart itself (Figure 6 G–L). Ctla2a is
expressed in the branchial arches and outflow tract of the E8.5
embryo, with expression later seen in the inflow tract, common
atria, right ventricle and outflow tract of the E9.5 embryo (Figure 6
M–N). AI430856 was expressed in the branchial arches and
outflow tract of the E8.5 mouse embryo (Figure 6O); in the E9.5
embryo, expression was observed in the branchial arches, inflow
tract, and outflow tract (Figure 6P). AI430856 was later identified
to be a portion of the 39 untranslated region (UTR) of the Hand2
gene, but the absence of expression in the right ventricle, in
contrast to the Hand2 gene [24], indicates a possible regulatory
role of this fragment. Finally, A730054J21Rik was expressed in the
inflow and outflow tract at E8.5 (Figure 6Q); at E9.5,
A730054J21Rik expression continued in the outflow tract, and
was also shown to be expressed in the spinal cord and a position
consistent with the forming gut (Figure 6R).
Finally, the expression of some candidates was only detectible
by E9.5, with Taok3 expression observed in the inflow tract,
common atria outflow tract, and otic vesicle of the E9.5 embryo
(Figure 6S); 9130005N14Rik expression observed in the inflow
tract, common atria, and outflow tract at E9.5 (Figure 6T);
Figure 4. Gene Ontology of Dataset Transcripts. Pie chart representing the relative abundance of transcripts within the dataset of genes
displaying significantly different levels in the contrast of Day 6 GFP
+ versus day 0, day 4 and day 6 GFP
2. Transcripts were classified according to Gene
Ontology (GO) terms. Annotated transcripts whose ontology could not be determined based on available information were classified as having
‘‘insufficient information’’. Transcripts with no annotation were also reported as ‘‘no annotation’’.
doi:10.1371/journal.pone.0002176.g004
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tract, common atria, spinal cord, and forming gut of E9.5
embryos (Figure 6U); and BQ947020 was expressed in the right
ventricle and CNS of the E9.5 embryo (Figure 6V). The remaining
eight candidates evaluated through in situ hybridization were
expressed in cardiac related structures such as the heart, outflow
tract, and branchial arches, as well as other embryonic structures
(Figure S2).
A table summarizing the results of 31 in situ hybridizations
completed in this study provides a listing of developmentally
important cardiac structures in which they are expressed (Table 2).
Our data demonstrate the successful utilization of mESCs to
model and illuminate early cardiac development. By acquiring a
transcriptional profile of these cells at multiple times during their
differentiation along a cardiac lineage, we have been able to
identify both known and novel transcripts expressed in early
Figure 5. Many Identified Candidates are Detected in the Cardiac Crescent. Embryonic expression of transcripts was evaluated in mice at
E7.5, E8.5 and E9.5. Nkx2-5 (A-C) and Isl1 (D-F) were used as anatomical controls for cardiac expression. 4930544G21Rik (G-I), AK080047 (J-L), Rbm24 (M-
O), Ppp1r3d (P-R), Tmem108 (S-U), Air (V-X), Arhgap29 (Y-AA), Igf2 (BB-DD), Igfbp5 (EE-GG) were all expressed in the cardiac crescent of E7.5 embryos
(arrowheads). HT, heart tube; H, heart; OFT, out flow tract; IFT, inflow tract; CA, common atria; RV, right ventricle; CNS, central nervous system; BA,
branchial arches; S, somites; OV otic vesicle; SC, spinal cord; DRG, dorsal root ganglia; E7.5-9.5; embryonic days 7.5-9.5.
doi:10.1371/journal.pone.0002176.g005
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PLoS ONE | www.plosone.org 7 May 2008 | Volume 3 | Issue 5 | e2176Figure 6. Candidate Genes are Frequently Expressed in Cardiac Structures. AK033658 (A–B), AI465270 (C–D), Unc45b (E–F), 1110062M06Rik
(G–H), Dlk1 (I–J), 8430436O14Rik (K–L), Ctla2a (M–N), AI430856 (O–P), and A730054J21Rik (Q–R) detected in cardiac structures at E8.5 and E9.5. Taok3
(S), 9130005N14Rik (T), Gab2 (U), and BQ947020 (V) detected in cardiac structures at E9.5. HT, heart tube; H, heart; OFT, out flow tract; IFT, inflow tract;
CA, common atria; RV, right ventricle; CNS, central nervous system; BA, branchial arches; S, somites; OV otic vesicle; SC, spinal cord; G, gut.
doi:10.1371/journal.pone.0002176.g006
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potential functional significance in cardiogenesis.
Discussion
Elucidating the genetic programs underlying developmental
processes is a central goal in contemporary medical research.
Small populations of target cells that are not easily isolated from
the surrounding tissue can complicate this challenge. We
demonstrate that in vitro differentiation strategies using mESCs
can effectively model the early stages of cardiogenesis, and that
established genomic technologies can be effectively used to
illuminate pertinent genetic signatures therein. Through the use
of the Nkx2-5-GFP ES cell line we have isolated a relatively pure
cardiac progenitor population for transcriptional profiling. By
comparing the cardiac progenitor population (D6 GFP
+) against
undifferentiated mESCs (D0), early differentiating mESCs (D4)
and non-cardiac multi-lineage mESCs (D6 GFP
2), we generated a
robust dataset represented by 260 unique transcripts significantly
differentially expressed (FDR of 0.001). We have validated the
integrity of this data through qRT-PCR and demonstrated its
concordance with a sample of genes identified in a previous ex vivo
analysis (Masino et al., 2004). Consistent with the underlying
premise of this experiment, 43/176 (24%) of the transcripts
Table 2. Summary of sites of Transcript Expression Detected by in situ Hybridization
Probeset ID Gene Symbol E7.5 E8.5 E9.5
1455040_s_at 1110062M06Rik No Signal BA, IFT, OFT
{ BA, IFT, OFT
{
1417877_at 2310005P05Rik No Signal No Signal BA, IFT, H, OFT
{
1435399_at 2310068J10Rik No Signal No Signal IFT, CA, OFT, CNS
{
1454926_at 4930544G21Rik Crescent IFT, HT, OFT IFT, CA, RV, OFT
1452762_at 8430436O14Rik No Signal BA, OFT BA, IFT, OFT, CNS
1452761_a_at 8430436O14Rik No Signal BA, OFT BA, IFT, OFT, CNS
1417272_at 9130005N14Rik No Signal No Signal IFT, CA, OFT
1438531_at A730054J21Rik No Signal IFT, OFT OFT, SC, G
1437401_at AI425372 No Signal No Signal BA, IFT, CA, OFT, CNS
{
1436041_at AI430856 No Signal BA, OFT BA, IFT, OFT
1438705_at AI465270 No Signal IFT, HT, OFT IFT, CA, OFT, S
1456139_at Air Crescent
{ BA, IFT, HT, OFT
{ BA, IFT, H, OFT
{
1435265_at AK033658 No Signal IFT IFT, CA, CNS
1434766_at AK080047 Crescent HT H, CNS
1454745_at Arhgap29 Crescent
{ BA, IFT, OFT
{ BA, IFT, CA, OFT
{
1434413_at BG092677 No Signal No Signal IFT, CA, OFT
{
1428891_at BI455251 No Signal DRG BA, CA, OFT, DRG
{
1437967_at BQ947020 No Signal No Signal CA, CNS
1416811_s_at Ctla2a /// Ctla2b No Signal BA, OFT
{ IFT, CA, RV, OFT
{
1452352_at Ctla2b No Signal BA, OFT
{ IFT, CA, RV, OFT
{
1449939_s_at Dlk1 No Signal BA, IFT, OFT
{ BA, IFT, OFT
{
1419829_a_at Gab2 No Signal No Signal BA, IFT, CA, OFT, G, SC
1440830_at Gpr116 No Signal No Signal BA, IFT, CA, OFT
{
1418379_s_at Gpr124 No Signal No Signal BA, IFT, OFT
{
1448152_at Igf2 Crescent
{ BA, IFT, HT, OFT
{ BA, IFT, H, OFT
{
1452114_s_at Igfbp5 Crescent
{ BA, IFT, OFT { BA, IFT, OFT, S
{
1452922_at Ppp1r3d Crescent IFT, OFT IFT, OFT, OV, S
1456180_at Rbm24 Crescent BA, IFT, HT, OFT H, S
1458624_at Rbm24 Crescent BA, IFT, HT, OFT H, S
1435964_a_at Taok3 No Signal No Signal IFT, CA, OFT, OV
1423250_a_at Tgfb2 No Signal BA, IFT, OFT
{ BA, IFT, OFT
{
1436916_at Tmem108 Crescent
{ IFT, HT, OFT IFT, H, OFT, CNS
1454729_at Tmem108 Crescent
{ IFT, HT, OFT IFT, H, OFT, CNS
1436939_at Unc45b No Signal IFT, HT, OFT IFT, H, OFT
1423835_at Zfp503 No Signal BA, OFT
{ BA, OFT
{
Sites of expression are tabulated for each of 31 candidates evaluated at each of 3 embryonic stages during cardiogenesis. HT, heart tube; H, heart; OFT, out flow tract;
IFT, inflow tract; CA, common atria; RV, right ventricle; CNS, central nervous system; BA, branchial arches; S, somites; OV otic vesicle; SC, spinal cord; G, gut; DRG, dorsal
root ganglia; E7.5–9.5; embryonic days 7.5–9.5;
{indicates expression of transcript was detected in many other structures throughout the embryo. No signal means that expression was not detected at that time point.
doi:10.1371/journal.pone.0002176.t002
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role in cardiogenesis or hematopoiesis, confirming the strength of
this dataset. While a significant fraction of the transcripts in this
dataset were of unknown function (52/260), we posit that many
play a role in cardiogenesis.
Analysis of the gene ontology of differentially expressed
transcripts, while imperfect, provides insight to the potential
interactions that underlie the fate determination that drives the
mesodermal subpopulation of differentiating mESCs along a
cardiac lineage. Although the complex signaling pathways
necessary for cardiogenesis are incompletely known, the large
number of transcripts in this dataset encoding transcription factors
(n=32) or genes involved in extracellular (n=24) or intracellular
(n=26) signal transduction provide novel avenues for the
investigation of cardiac development. While some of the
transcription factors identified in this study, such as Nkx2-5,
Tbx5, and Mef2c, have an established role in cardiogenesis, many
do not, making them ideal candidates for further appraisal.
Finally, the large number of transcripts with no (n=52) or
incomplete (n=27) annotation offer an equally novel foundation
for future work in this field. Importantly, the candidacy of several
novel players must first be dependent on a demonstration of their
biological relevance to cardiogenesis.
We set out to establish the biological relevance of a large subset
of candidates through in situ hybridization during embryogenesis
and in doing so we uncovered a wide range of expression patterns
consistent with cardiogenesis. Most significantly, nine of the 31
candidates (29%) (4930544G21Rik, Ak080047, Rbm24, Ppp1r3d,
Tmem108, Air, Arhgap29, Igf2, and Igfbp5) are expressed in the
forming cardiac crescent (E7.5). The expression of these genes is
consistent with their potential role in the formation of the earliest
cardiac structures. Furthermore, these genes continue to be
expressed at subsequent time points (E8.5, E9.5) consistent with
a possible role in the maintenance or maturation of cardiac
lineages. Although transcripts corresponding to the remaining 22
candidates evaluated in this study were not detected at E7.5, all
were shown to be expressed in cardiovascular tissues at later time
points (E8.5, E9.5). The expression of these transcripts at later time
points does not diminish their potential importance in cardiogen-
esis; they may also play significant roles in the maturation of the
early cardiogenic population, or the morphological changes to the
structure of the looping heart.
While many of these candidates are expressed solely in cardiac
structures, the expression of most major cardiac genes extends
beyond the cardiovascular system. Nkx2-5, for example, is also
expressed in the foregut, thyroid, spleen, stomach and tongue [25];
similarly, in addition to the outflow tract Isl1 is expressed in the
spinal cord, dorsal root ganglia, and trigeminal ganglia at E9.5;
and Tbx5 is expressed in both the heart as well as the limb bud
[26]. Consistent with these observations, many of the candidates
evaluated in this study are also expressed in both cardiac and non-
cardiac structures.
Importantly Nkx2-5 is expressed in both the primary and
secondary heart fields. Consequently we anticipated that our
transcriptional analyses could identify transcripts present in both
heart fields, as well as those exclusively present in one heart field.
Of the candidate genes investigated, we would predict Igfbp5,
4930544G21Rik, and Ppp1r3d are expressed in the secondary heart
field at E7.5. Consistent with lineage tracing experiments of the
secondary heart field [3,5], these genes are later expressed in the
outflow tract at E8.5 and E9.5 and the developing atria and right
ventricle at E9.5. Conversely, AK080047 is expressed in a region
consistent with the primary heart field at E7.5, with later
expression in the linear heart tube at E8.5 and throughout the
heart entire heart at E9.5. These examples underscore the ability
of the Nkx2-5-GFP cell line to isolate multiple populations of cells
that contribute to the developing heart.
Although the candidate genes whose biological relevance has
been evaluated in this study represent an incomplete sample of the
total dataset, we have shown that many transcripts with no prior
functional annotation display expression tight and specific patterns
consistent with genes involved in cardiogenesis. While we have not
experimentally validated the biological relevance of every
transcript that is upregulated in the cardiac fated GFP
+
population, taken in concert with published data we demonstrate
that more than 40% (74/176) had expression patterns consistent
with a role in cardiogenesis. First, 24% (43/176) of the genes
identified in this screen are known to have an established role in
cardiogenesis or hematopoiesis. Second, of the genes upregulated
in the cardiac fated population, but lacking an identified role in
cardiogenesis (133/176), 31 are detected in early cardiac structures
by in situ hybridization. Taken collectively, these data strongly
support the utility of mESCs to model early cardiac development.
These data will serve as a great resource as we continue to
investigate the mechanisms of cardiac development; focusing on
further exploration of this dataset and characterizing the
mechanisms by which these newly identified cardiac genes
participate in cardiac development.
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